Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-14 Sale |
2021-07-16 6:21 pm |
Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO |
34,017 | $3.71 | $126,203 | 817,806 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-08 Option Award |
2022-04-12 5:34 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
204,399 | $0 | 204,399 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 5:30 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
35,399 | $0 | 35,399 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 4:55 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
21,347 | $0 | 21,347 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 4:44 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
69,424 | $0 | 69,424 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:51 pm |
N/A 2032-02-03 |
Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:50 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:49 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:48 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:47 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:24 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:22 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
218,750 | $0 | 218,750 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:19 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 6:14 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner |
600,000 | $0 | 600,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-07 4:44 pm |
N/A 2031-10-05 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-07-14 Exercise |
2021-07-16 6:21 pm |
N/A N/A |
Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO |
34,017 | $1.89 | 817,806 (Direct) |
View |
| 2021-07-14 Exercise |
2021-07-16 6:21 pm |
N/A 2029-02-23 |
Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO |
34,017 | $0 | 817,806 (Direct) |
View |
| 2021-07-09 Option Award |
2021-07-13 4:25 pm |
N/A 2031-07-08 |
Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 4:23 pm |
N/A 2031-06-30 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-11 8:31 pm |
N/A 2031-06-10 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-11 8:22 pm |
N/A 2031-06-10 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-11 8:15 pm |
N/A 2031-06-10 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-10 7:49 pm |
N/A 2031-06-01 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 9:04 pm |
N/A 2031-05-16 |
Ovid Therapeutics Inc. | OVID | WILLIAMS DOUGLAS E Director |
1,750 | $0 | 1,750 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 9:00 pm |
N/A 2031-05-16 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
1,750 | $0 | 1,750 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 8:57 pm |
N/A 2031-05-16 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
1,750 | $0 | 1,750 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 8:51 pm |
N/A 2031-05-16 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
1,750 | $0 | 1,750 (Direct) |
View |
| 2020-11-25 Option Award |
2021-04-29 5:32 pm |
2020-11-25 2030-05-04 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
44,000 | $0 | 44,000 (Direct) |
View |
| 2020-11-25 Option Award |
2021-04-29 5:30 pm |
2020-11-25 2030-05-04 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer |
44,000 | $0 | 44,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-08 8:27 pm |
2021-02-05 2030-06-19 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 5:08 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 5:04 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
175,000 | $0 | 175,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:58 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:53 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Rakhit Amit President and CMO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:45 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner |
650,000 | $0 | 650,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:38 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Haasner Dirk SVP, Global Regulatory Affairs |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:34 pm |
N/A 2030-12-16 |
Ovid Therapeutics Inc. | OVID | Daly Timothy EVP,Finance & Corp. Controller |
125,000 | $0 | 125,000 (Direct) |
View |
| 2020-10-11 Option Award |
2020-10-13 4:46 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A Chief Business Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-10-11 Option Award |
2020-10-13 4:41 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Haasner Dirk SVP, Global Regulatory Affairs |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-10-11 Option Award |
2020-10-13 4:38 pm |
N/A 2030-10-10 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
20,000 | $0 | 20,000 (Direct) |
View |